WHO vaccine-preventable diseases: monitoring system. 2015 global summary

Last updated 28-May-2015 (Data received as of 22-May-2015)
Next overall update July 2015
2014 data are provisional
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 1 Infant (under 12 months) mortality rate: 132
GDP / capita (US$): 21'3971 Child (under 5 years) mortality rate: 152

Population data in thousands3

  2014  2013  2012  2011  2010  2000  1990  1980 
Total population 6'253  6'202  6'155  6'103  6'041  5'176  4'260  3'078 
Births 127  129  130  131  132  116  122  129 
Surviving infants 125  127  128  129  130  113  118  121 
Pop. less than 5 years 636  641  645  646  644  548  601  565 
Pop. less than 15 years 1'840  1'826  1'811  1'796  1'779  1'723  1'785  1'419 
Female 15-49 years 1'772  1'756  1'739  1'721  1'700  1'359  924  617 

Number of reported case

(Click for retrospective incidence data for Libya)
Diphtheria
Japanese encephalitis
Measles 372  320  931  1'547 
Mumps 111 
Pertussis 197  43  25 
Polio* 30 
Rubella
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)** 30 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Libya)
Vaccine year result method % card seen                                                
BCG 2006  100  FHS   81  99*  99*  90  88 
DTP1 2006  100  FHS   81  98  99 
DTP3 2006  98  FHS   81  97  98  84  60 
HepB_BD          99*  99* 
HepB3          97  98 
Hib3          97  98 
JapEnc         
MCV          98  98  89  61 
MCV2          97  97 
PCV1          98 
PCV3          97 
Pol3 2006  98  FHS   81  97  98  84  60 
Rota1          98 
Rota_last          97 
Rubella1          98  98 
TT2plus          18 
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Libya)
BCG 99  99  99  99  98  90  88 
DTP1 99  99  99  98  97  94  82 
DTP3 98  98  98  98  94  84  60 
HepB3 98  98  98  98  92 
HepB_BD 99  99  99  99 
Hib3 98  98  98  98 
MCV 98  98  98  98  93  89  61 
MCV2 97  97  97  97 
PCV3
Pol3 98  98  98  98  94  84  60 
Rota_last

Number of districts in the country 32  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 84
From 80 to 89% 16
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2014 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTaPHibHepIPV 2, 4, 6 months;
DTwP 18 months; Yes
HPV 15 years (3 doses); Yes
HepB birth; Yes and not vaccinated adults
IPV 14 weeks; Yes
Influenza >60 years Yes Elderly with chronic illness, pregnant women, health care workers, Hajj and other travellers
MMR 12, 18 months; Yes
MenACWY 9,12 months; 6 years; Yes
OPV birth; 2, 4, 6, 18 months; 6,15 years; Yes
Pneumo_conj 2, 4, 12 months; Yes
Pneumo_ps Yes adults - risk groups
Rotavirus 2, 4, 6 months; Yes
Td 6, 15 years; Yes
YF Yes travelers

Immunizaton indicators

Indicator Expected answer 2014  2013  2012  2011  2010  2009  2008 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR No    Yes      Yes  Yes 
What years does the MYP cover? number     2008-2012      2008-2012  2008 - 2012 
Nº of districts with microplans that include activities to raise immunization coverage number              

System performance

Total Nº districts in country number 32    30      23  23 
Nº districts with DTP3 coverage >=80% number 32    30      23  23 
% of districts with DTP3 coverage >=80% From 0 to 100% 100    100      100  100 
Nº districts with measles (MCV1) coverage >=95% number   17      16  10 
% of districts with MCV1 coverage >=95% From 0 to 100% 19    57      70  43 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes    Yes         
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR No    No      No  No 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100%           100  100 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes    Yes         

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.